Current and historical daily PE Ratio for TECH (
Bio-Techne Corp
) from 1992 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bio-Techne stock (TECH) PE ratio as of Jun 08 2024 is 61.61.
More Details
Bio-Techne Corp (TECH) PE Ratio (TTM) Chart
Bio-Techne Corp (TECH) PE Ratio (TTM) Historical Data
View and export this data going back to 1992. Start your Free Trial
Total 1246
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Bio-Techne PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | 61.6 | 2024-04-05 | 53.2 |
| 2024-06-07 | 61.6 | 2024-04-04 | 53.2 |
| 2024-06-06 | 62.6 | 2024-04-03 | 53.9 |
| 2024-06-05 | 62.9 | 2024-04-02 | 54.6 |
| 2024-06-04 | 61.0 | 2024-04-01 | 55.1 |
| 2024-06-03 | 61.8 | 2024-03-28 | 55.9 |
| 2024-05-31 | 61.3 | 2024-03-27 | 50.3 |
| 2024-05-30 | 61.3 | 2024-03-26 | 49.6 |
| 2024-05-29 | 62.4 | 2024-03-25 | 50.2 |
| 2024-05-28 | 63.0 | 2024-03-22 | 51.8 |
| 2024-05-24 | 64.1 | 2024-03-21 | 52.4 |
| 2024-05-23 | 63.8 | 2024-03-20 | 52.1 |
| 2024-05-22 | 65.9 | 2024-03-19 | 51.3 |
| 2024-05-21 | 65.6 | 2024-03-18 | 52.1 |
| 2024-05-20 | 65.5 | 2024-03-15 | 52.5 |
| 2024-05-17 | 66.5 | 2024-03-14 | 51.6 |
| 2024-05-16 | 65.8 | 2024-03-13 | 52.5 |
| 2024-05-15 | 66.3 | 2024-03-12 | 53.7 |
| 2024-05-14 | 66.8 | 2024-03-11 | 54.4 |
| 2024-05-13 | 65.1 | 2024-03-08 | 55.9 |
| 2024-05-10 | 64.2 | 2024-03-07 | 55.8 |
| 2024-05-09 | 63.2 | 2024-03-06 | 54.1 |
| 2024-05-08 | 61.1 | 2024-03-05 | 53.2 |
| 2024-05-07 | 61.5 | 2024-03-04 | 54.3 |
| 2024-05-06 | 60.4 | 2024-03-01 | 53.9 |
| 2024-05-03 | 61.3 | 2024-02-29 | 53.3 |
| 2024-05-02 | 60.0 | 2024-02-28 | 53.9 |
| 2024-05-01 | 58.3 | 2024-02-27 | 53.0 |
| 2024-04-30 | 50.2 | 2024-02-26 | 52.1 |
| 2024-04-29 | 51.2 | 2024-02-23 | 51.9 |
| 2024-04-26 | 50.8 | 2024-02-22 | 52.0 |
| 2024-04-25 | 49.7 | 2024-02-21 | 52.0 |
| 2024-04-24 | 50.4 | 2024-02-20 | 51.0 |
| 2024-04-23 | 50.5 | 2024-02-16 | 51.9 |
| 2024-04-22 | 49.8 | 2024-02-15 | 51.6 |
| 2024-04-19 | 49.3 | 2024-02-14 | 50.8 |
| 2024-04-18 | 49.4 | 2024-02-13 | 48.9 |
| 2024-04-17 | 49.8 | 2024-02-12 | 50.7 |
| 2024-04-16 | 50.8 | 2024-02-09 | 49.2 |
| 2024-04-15 | 52.0 | 2024-02-08 | 49.3 |
| 2024-04-12 | 53.0 | 2024-02-07 | 48.1 |
| 2024-04-11 | 54.6 | 2024-02-06 | 48.8 |
| 2024-04-10 | 55.2 | 2024-02-05 | 48.4 |
| 2024-04-09 | 56.5 | 2024-02-02 | 47.8 |
| 2024-04-08 | 54.1 | 2024-02-01 | 49.7 |
Bio-Techne Corp (TECH) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Bio-Techne Corp
NAICS : 325414
SIC : 2836
ISIN : US09073M1045
Share Class Description:
TECH: Ordinary SharesCompare
Compare
Traded in other countries / regions
TECH.USAT1CH34.BrazilTE1.GermanyTECH.Mexico IPO Date
1992-12-09Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers